Cited by 1,108Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementCardiovascular and Diving-Related Complications

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Atrial Fibrillation: A Major Contributor to Stroke in the Elderly: The Framingham Study

Wolf, Philip A.·1987·Archives of Internal Medicine

DOI 10.1001/archinte.1987.00370090041008

Open this paper in CoChat — free account

Abstract

• Chronic atrial fibrillation without valvular disease has been associated with increased stroke incidence. The impact of atrial fibrillation on the risk of stroke with increasing age was examined in 5184 men and women in the Framingham Heart Study. After 30 years of follow-up, chronic atrial fibrillation appeared in 303 persons. Age-specific incidence rates steadily increased from 0.2 per 1000 for ages 30 to 39 years to 39.0 per 1000 for ages 80 to 89 years. The proportion of strokes associated with this arrhythmia was 14.7%, 68 of the total 462 initial strokes, increasing steadily with age from 6.7% for ages 50 to 59 years to 36.2% for ages 80 to 89 years. In contrast to the impact of cardiac failure, coronary heart disease, and hypertension, which declined with age, atrial fibrillation was a significant contributor to stroke at all ages. (Arch Intern Med1987;147:1561-1564)

Integrity signals

Registry

Crossref · 10.1001/archinte.1987.00370090041008

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The publisher hasn’t deposited this paper’s reference list.

Sorted by citations

Items 101–200 of 1,008

Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation
Marinigh, R., Lane, D. A., & Lip, G. Y. H. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.12.013 · Cited by 195
Ximelagatran versus warfarin forstroke prevention in patientswith nonvalvular atrial fibrillation
Petersen, P., Grind, M., & Adler, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00255-9 · Cited by 187
Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis
Choudhry, N. K., Anderson, G., Laupacis, A., Ross‐Degnan, D., Normand, S. T., & Soumerai, S. B. (2006) · BMJ · doi:10.1136/bmj.38698.709572.55 · Cited by 184
Stroke registry in Malmö, Sweden.
Jerntorp, P., & Berglund, G. (1992) · Stroke · doi:10.1161/01.str.23.3.357 · Cited by 181
Controversies in atrial fibrillation
Nattel, S., & Opie, L. H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68037-9 · Cited by 180
Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: An analysis from ASSERT
Kaufman, E. S., Israel, C. W., Nair, G. M., Armaganijan, L., Divakaramenon, S., Mairesse, G. H., Brandes, A., Crystal, E., Costantini, O., Sandhu, R. K., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.03.017 · Cited by 178
Stroke prophylaxis in atrial fibrillation: who gets it and who does not?
Friberg, L., Hammar, N., Ringh, M., Pettersson, H., & Rosenqvist, M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl146 · Cited by 175
Chronic Heart Failure and Ischemic Stroke
Hæusler, K. G., Laufs, U., & Endres, M. (2011) · Stroke · doi:10.1161/strokeaha.111.628479 · Cited by 175
Left Ventricular Systolic Dysfunction and the Risk of Ischemic Stroke in a Multiethnic Population
Hays, A. G., Sacco, R. L., Rundek, T., Sciacca, R. R., Jin, Z., Liu, R., Homma, S., & Tullio, M. R. D. (2006) · Stroke · doi:10.1161/01.str.0000227121.34717.40 · Cited by 173
Mediterranean Dietary Patterns and Cardiovascular Health
Shen, J., Wilmot, K. A., Ghasemzadeh, N., Molloy, D. L., Burkman, G. M., Mekonnen, G., Góngora, M. C., Quyyumi, A. A., & Sperling, L. S. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-011215-025104 · Cited by 179
Multicenter Low Energy Transvenous Atrial Defibrillation (XAD) Trial Results in Different Subsets of Atrial Fibrillation
Lévy, S., Ricard, P., Lau, C., Lok, N.-S., Camm, A. J., MURGATROYD, F. D., Jordaens, L. J. L. M., KAPPENBERGER, L. J., Brugada, P., & Ripley, K. L. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00583-9 · Cited by 172
Newly Diagnosed Atrial Fibrillation and Acute Stroke
Lin, H., Wolf, P. A., Benjamin, E. J., Belanger, A. J., & D’Agostino, R. B. (1995) · Stroke · doi:10.1161/01.str.26.9.1527 · Cited by 171
Self-citation
Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment
Eikelboom, J. W., O'Donnell, M. J., Yusuf, S., Díaz, R., Flaker, G. C., Hart, R. G., Hohnloser, S. H., Joyner, C. D., Lawrence, J., Pais, P., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2009.08.026 · Cited by 163
Comparison of Stroke Features and Disability in Daily Life in Patients With Ischemic Stroke Aged 55 to 70 and 71 to 85 Years
Pohjasvaara, T., Erkinjuntti, T., Vataja, R., & Kaste, M. (1997) · Stroke · doi:10.1161/01.str.28.4.729 · Cited by 161
Meta-analysis: Inhibition of renin-angiotensin system prevents new-onset atrial fibrillation
Anand, K., Mooss, A. N., Hee, T. T., & Mohiuddin, S. M. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.01.007 · Cited by 159
Tachycardia-Induced Change of Atrial Refractory Period in Humans
Yu, W., Chen, S.-A., Lee, S.-H., TAI, C., Feng, A.-N., Kuo, B. I., Ding, Y.-A., & Chang, M.-S. (1998) · Circulation · doi:10.1161/01.cir.97.23.2331 · Cited by 160
Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials
Rahimi, K., Emberson, J., McGale, P., Majoni, W., Merhi, A., Asselbergs, F. W., Krane, V., Macfarlane, P. W., & Executive, P. I. A. O. B. O. T. P. (2011) · BMJ · doi:10.1136/bmj.d1250 · Cited by 159
Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II
Essien, U. R., Holmes, D. N., Jackson, L. R., Fonarow, G. C., Mahaffey, K. W., Reiffel, J. A., Steinberg, B. A., Allen, L. A., Chan, P. S., Freeman, J. V., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.3945 · Cited by 155
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older
Tanné, D., Gorman, M., Bates, V. E., Kasner, S. E., Scott, P., Verro, P., Binder, J. R., Dayno, J. M., Schultz, L. R., & Levine, S. R. (2000) · Stroke · doi:10.1161/01.str.31.2.370 · Cited by 155
Percutaneous Left Atrial Appendage Closure
Saw, J., & Lempereur, M. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2014.05.026 · Cited by 157
Prevention of stroke in patients with nonvalvular atrial fibrillation
Hart, R. G., Sherman, D. G., Easton, J. D., & Cairns, J. A. (1998) · Neurology · doi:10.1212/wnl.51.3.674 · Cited by 153
Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin
Zalesak, M., Siu, K., Francis, K. M., Chen, Y. X., Alvrtsyan, H., Rao, Y., Walker, D. R., Sander, S. D., Miyasato, G., Matchar, D. B., et al. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000192 · Cited by 151
Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality
Melduni, R. M., Schaff, H. V., Lee, H.-C., Gersh, B. J., Noseworthy, P. A., Bailey, K. R., Ammash, N. M., Cha, S. S., Fatema, K., Wysokiński, W. E., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.021952 · Cited by 151
Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation
O’Brien, C. L. (2005) · JAMA · doi:10.1001/jama.293.6.699 · Cited by 149
Physician Attitudes Concerning Warfarin for Stroke Prevention in Atrial Fibrillation: Results of a Survey of Long‐Term Care Practitioners
Monette, J., Gurwitz, J. H., Rochon, P. A., & Avorn, J. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb05967.x · Cited by 149
Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation
Klein, A. L., Murray, R. D., & Grimm, R. A. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01178-5 · Cited by 146
Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study
Saliba, W., Gronich, N., Barnett‐Griness, O., & Rennert, G. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.02.029 · Cited by 146
Effects of the Maze Operation on Health-Related Quality of Life in Patients With Atrial Fibrillation
Lönnerholm, S., Blomström, P., Nilsson, L., Oxelbark, S., Jidéus, L., & Blomström‐Lundqvist, C. (2000) · Circulation · doi:10.1161/01.cir.101.22.2607 · Cited by 145
Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism
Fang, M. C. (2010) · Patient Preference and Adherence · doi:10.2147/ppa.s6101 · Cited by 144
Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial
Matchar, D. B., Samsa, G. P., Cohen, S. J., Oddone, E. Z., & Jurgelski, A. E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01131-2 · Cited by 141
Dronedarone
Patel, C., Yan, G., & Kowey, P. R. (2009) · Circulation · doi:10.1161/circulationaha.109.858027 · Cited by 141
Circadian Variation of Paroxysmal Atrial Fibrillation
Yamashita, T., Murakawa, Y., Sezaki, K., Inoue, M., Hayami, N., Shuzui, Y., & Omata, M. (1997) · Circulation · doi:10.1161/01.cir.96.5.1537 · Cited by 138
Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction
Rosenqvist, M., Lee, M. A., Moulinier, L., Springer, M. J., Abbott, J. A., Wu, J. T., Langberg, J. J., Griffin, J. C., & Scheinman, M. M. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90394-5 · Cited by 132
Risk factors for stroke in patients with nonrheumatic atrial fibrillation: A case-control study
Moulton, A. W., Singer, D. E., & Haas, J. S. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90008-l · Cited by 130
Importance of Considering Competing Risks in Time-to-Event Analyses
Abdel-Qadir, H. M., Fang, J., Lee, D. S., Tu, J. V., Amir, E., Austin, P. C., & Anderson, G. (2018) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.004580 · Cited by 127
Cellular and Molecular Mechanisms of Arrhythmia by Oxidative Stress
Sovari, A. A. (2016) · Cardiology Research and Practice · doi:10.1155/2016/9656078 · Cited by 126
Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German Ablation Registry
SCHMIDT, M., DORWARTH, U., ANDRESEN, D., BRACHMANN, J., KUCK, K., KUNISS, M., LEWALTER, T., SPITZER, S., WILLEMS, S., SENGES, J., et al. (2014) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12267 · Cited by 126
ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association
Arbelo, E., Brugada, J., Hindricks, G., Maggioni, A. P., Tavazzi, L., Vardas, P. E., Anselme, F., Inama, G., Jaı̈s, P., Kalarus, Z. F., et al. (2012) · EP Europace · doi:10.1093/europace/eus153 · Cited by 125
Left atrial appendage occlusion
Holmes, D. R., Korsholm, K., Rodés‐Cabau, J., Saw, J., Berti, S. L., & Alkhouli, M. A. (2023) · EuroIntervention · doi:10.4244/eij-d-22-00627 · Cited by 126
Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation
Bekwelem, W., Connolly, S. J., Halperin, J. L., Adabağ, S., Duval, S., Chrolavicius, S., Pogue, J. M., Ezekowitz, M. D., Eikelboom, J. W., Wallentin, L. C., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013243 · Cited by 122
Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation
Antani, M. R., Beyth, R. J., Covinsky, K. E., Anderson, P. A., Miller, D. G., Cebul, R. D., Quinn, L., & Landefeld, C. S. (1996) · Journal of General Internal Medicine · doi:10.1007/bf02598984 · Cited by 121
Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation
Rockson, S. G., & Albers, G. W. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.028 · Cited by 121
Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation
Stoddard, M. F., Dawkins, P. R., Prince, C. R., & Longaker, R. A. (1995) · American Heart Journal · doi:10.1016/0002-8703(95)90405-0 · Cited by 120
2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry
Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P. F., Balsam, P., Baranchuk, A. M., Cantillon, D. J., Dilaveris, P., Dubner, S., El‐Sherif, N., et al. (2017) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12447 · Cited by 123
Left atrial function to identify patients with atrial fibrillation at high risk of stroke: new insights from a large registry
Leung, M., van Rosendael, P. J., Abou, R., Marsan, N. A., Leung, D. Y., Delgado, V., & Bax, J. J. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx736 · Cited by 116
Use of anticoagulants in elderly patients: practical recommendations
Righini, M. (2009) · Clinical Interventions in Aging · doi:10.2147/cia.s4308 · Cited by 114
Why isn’t warfarin prescribed to patients with nonrheumatic atrial fibrillation?
Beyth, R. J., Antani, M. R., Covinsky, K. E., Miller, D. G., Chren, M., Quinn, L., & Landefeld, C. S. (1996) · Journal of General Internal Medicine · doi:10.1007/bf02598985 · Cited by 114
Thromboembolism Prophylaxis in Chronic Atrial Fibrillation
Munschauer, F. E., Priore, R. L., Hens, M. M., & Castilone, A. (1997) · Stroke · doi:10.1161/01.str.28.1.72 · Cited by 110
Effects of Stroke on the Autonomic Nervous System
Dorrance, A. M., & Fink, G. D. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140016 · Cited by 121
Elevated Platelet Microparticle Levels in Nonvalvular Atrial Fibrillation
Choudhury, A., Chung, I. K.-K., Blann, A. D., & Lip, G. Y. H. (2007) · CHEST Journal · doi:10.1378/chest.06-2039 · Cited by 108
Prevalence of and Risk Factors for Atrial Fibrillation in Korean Adults Older than 40 Years
Jeong, J. H. (2005) · Journal of Korean Medical Science · doi:10.3346/jkms.2005.20.1.26 · Cited by 107
Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation
Aronow, W. S., Gutstein, H., & Hsieh, F. Y. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90349-4 · Cited by 107
Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation?
Singer, D. E., Chang, Y., Fang, M. C., Borowsky, L. H., Pomernacki, N. K., Udaltsova, N. V., & Go, A. S. (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.830232 · Cited by 106
Automatic Cardiac Event Recorders Reveal Paroxysmal Atrial Fibrillation after Unexplained Strokes or Transient Ischemic Attacks
Barthélemy, J., Féasson‐Gérard, S., Garnier, P., Gaspoz, J., Costa, A. D., Michel, D., & Roche, F. (2003) · Annals of Noninvasive Electrocardiology · doi:10.1046/j.1542-474x.2003.08305.x · Cited by 104
Predictors of stroke mortality in elderly people from the general population
Mazza, A., Pessina, A. C., Pavei, A., Scarpa, R., Tikhonoff, V., & Casiglia, E. (2001) · European Journal of Epidemiology · doi:10.1023/a:1021216713504 · Cited by 105
Association between 24-h blood pressure monitoring variables and brain oedema in patients with hyperacute stroke
Vemmos, K. N., Tsivgoulis, G. K., Spengos, K. M., Zakopoulos, N., Synetos, A. G., Kotsis, V., Vassilopoulos, D., & Mavrikakis, M. (2003) · Journal of Hypertension · doi:10.1097/00004872-200311000-00027 · Cited by 104
Screening for atrial fibrillation in primary care
Wheeldon, N. M., Tayler, D. I., Anagnostou, E., Cook, D. J., Wales, C., & Oakley, G. D. (1998) · Heart · doi:10.1136/hrt.79.1.50 · Cited by 104
Time Trends of Ischemic Stroke Incidence and Mortality in Patients Diagnosed With First Atrial Fibrillation in 1980 to 2000: Report of a Community-Based Study
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Seward, J. B., Bailey, K. R., Iwasaka, T., & Tsang, T. S. M. (2005) · Stroke · doi:10.1161/01.str.0000185927.63746.23 · Cited by 103
Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression
Mearns, E. S., White, C. M., Kohn, C. G., Hawthorne, J., Song, J.-S., Meng, J., Schein, J. R., Raut, M. K., & Coleman, C. I. (2014) · Thrombosis Journal · doi:10.1186/1477-9560-12-14 · Cited by 106
Epidemiological Profile of Atrial Fibrillation: A Contemporary Perspective
Tsang, T. S. M., Miyasaka, Y., Barnes, M. E., & Gersh, B. J. (2005) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2005.06.001 · Cited by 101
Serial Electrocardiographic Assessments Significantly Improve Detection of Atrial Fibrillation 2.6-Fold in Patients With Acute Stroke
Douen, A. G., Pageau, N., & Medic, S. (2008) · Stroke · doi:10.1161/strokeaha.107.492595 · Cited by 102
Population-Based Screening for Atrial Fibrillation
Khurshid, S. S., Healey, J. S., McIntyre, W. F., & Lubitz, S. A. (2020) · Circulation Research · doi:10.1161/circresaha.120.316341 · Cited by 104
Stroke prevention in nonvalvular atrial fibrillation: A review of prospective randomized trials
Albers, G. W., Sherman, D. G., Gress, D. R., Paulseth, J. E., & Petersen, P. (1991) · Annals of Neurology · doi:10.1002/ana.410300402 · Cited by 101
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation
Dorian, P., Kongnakorn, T., Phatak, H. M., Rublee, D. A., Kuznik, A., Lanitis, T., Lz, L., Iloeje, U., Hernandez, L. G., & Lip, G. Y. H. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu006 · Cited by 99
Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events
The ACTIVE Steering Committee (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.06.026 · Cited by 99
Feasibility of Extended Ambulatory Electrocardiogram Monitoring to Identify Silent Atrial Fibrillation in High‐risk Patients: The Screening Study for Undiagnosed Atrial Fibrillation ( STUDY‐AF )
Turakhia, M. P., Ullal, A. J., Hoang, D. D., Than, C. T., Miller, J. D., Friday, K. J., Perez, M. V., Freeman, J. V., Wang, P. J., & Heidenreich, P. A. (2015) · Clinical Cardiology · doi:10.1002/clc.22387 · Cited by 98
Brief Episodes of Silent Atrial Fibrillation Predict Clinical Vascular Brain Disease in Type 2 Diabetic Patients
Marfella, R., Sasso, F. C., Siniscalchi, M., Cirillo, M., Paolisso, P., Sardu, C., Barbieri, M., Rizzo, M. R., Mauro, C., & Paolisso, G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.091 · Cited by 96
Vitamin K: A Practical Guide to the Dietary Management of Patients on Warfarin
Booth, S. L., & Centurelli, M. A. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1999.tb01815.x · Cited by 94
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial
Mahaffey, K. W., Stevens, S. R., White, H. D., Nessel, C. C., Goodman, S. G., Piccini, J. P., Patel, M. R., Becker, R. C., Halperin, J. L., Hacke, W., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht428 · Cited by 92
Incident stroke after discharge from the hospital with a diagnosis of atrial fibrillation
Frost, L., Engholm, G., Johnsen, S. P., Møller, H., & Husted, S. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00415-5 · Cited by 95
Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study
Mancia, G., Ambrosioni, E., Rosei, E. A., Leonetti, G., Trimarco, B., & Volpe, M. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000175932.78774.32 · Cited by 92
Atrial Fibrillation in Older People: Concepts and Controversies
Zathar, Z., Karunatilleke, A., Fawzy, A. M., & Lip, G. Y. H. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00175 · Cited by 94
The Genetic Architecture of Intracerebral Hemorrhage
Rost, N. S., Greenberg, S. M., & Rosand, J. M. (2008) · Stroke · doi:10.1161/strokeaha.107.501650 · Cited by 93
Incident Atrial Fibrillation and Risk of Death in Adults With Chronic Kidney Disease
Bansal, N., Fan, D., Hsu, C., Ordoñez, J. D., & Go, A. S. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001303 · Cited by 89
What is the Impact of Frailty on Prescription of Anticoagulation in Elderly Patients with Atrial Fibrillation? A Systematic Review and Meta-Analysis
Oqab, Z. (2018) · Journal of Atrial Fibrillation · doi:10.4022/jafib.1870 · Cited by 90
Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation
Demircan, C. (2005) · Emergency Medicine Journal · doi:10.1136/emj.2003.012047 · Cited by 87
Genomics and Cardiac Arrhythmias
Roberts, R. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.059 · Cited by 87
Trend in Mortality after Stroke with Atrial Fibrillation
Frost, L., Andersen, L. V., Vestergaard, P., Husted, S., & Mortensen, L. S. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.12.027 · Cited by 86
Racial/Ethnic Differences in Ischemic Stroke Rates and the Efficacy of Warfarin Among Patients With Atrial Fibrillation
Shen, A. Y., Yao, J. F., Brar, S. S., Jorgensen, M. B., Wang, X., & Chen, W. (2008) · Stroke · doi:10.1161/strokeaha.107.508580 · Cited by 86
Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation
Singh, S., Saini, R. K., Dimarco, J., Kluger, J., Gold, R. L., & Chen, Y. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90200-5 · Cited by 85
Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study
Turakhia, M. P., Hoang, D. D., Xu, X., Frayne, S. M., Schmitt, S. K., Yang, F., Phibbs, C. S., Than, C. T., Wang, P. J., & Heidenreich, P. A. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.10.010 · Cited by 84
Antibodies Against Myosin in Sera of Patients with Idiopathic Paroxysmal Atrial Fibrillation
Maixent, J. M., Paganelli, F. F., Scaglione, J., & Lévy, S. (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb00942.x · Cited by 84
Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation
Nelson, W. W., Song, X., Coleman, C. I., Thomson, E., Smith, D. M., Damaraju, C. V., & Schein, J. R. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.933577 · Cited by 83
Patients’ and physicians’ perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review
Dalmau, G. M., Arderiu, E. S. I., Montes, M. E., Solà, I., Pequeño, S., & Alonso‐Coello, P. (2017) · BMC Family Practice · doi:10.1186/s12875-016-0574-0 · Cited by 83
Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation
Savelieva, I., & Camm, A. J. (2013) · Clinical Cardiology · doi:10.1002/clc.22204 · Cited by 84
Atrial Fibrillation Is Associated With Lower Cognitive Performance in the Framingham Offspring Men
Elias, M. F., Sullivan, L. M., Elias, P. K., Vasan, R. S., D’Agostino, R. B., Seshadri, S., Au, R., Wolf, P. A., & Benjamin, E. J. (2006) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2006.05.009 · Cited by 80
Self-citation
Plasma Brain Natriuretic Peptide Can be a Biological Marker to Distinguish Cardioembolic Stroke from Other Stroke Types in Acute Ischemic Stroke
Shibazaki, K., Kimura, K., Iguchi, Y., Okada, Y., & Inoue, T. (2009) · Internal Medicine · doi:10.2169/internalmedicine.48.1475 · Cited by 81
Risk Factors for In-hospital Nonhemorrhagic Stroke in Patients With Acute Myocardial Infarction Treated With Thrombolysis
Mahaffey, K. W., Granger, C. B., Sloan, M. A., Thompson, T., Gore, J. M., Weaver, W. D., White, H. D., Simoons, M. L., Barbash, G. I., Topol, E. J., et al. (1998) · Circulation · doi:10.1161/01.cir.97.8.757 · Cited by 79
Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention
Peterson, G. M., Boom, K., Jackson, S., & Vial, J. H. (2002) · Internal Medicine Journal · doi:10.1046/j.1445-5994.2002.00156.x · Cited by 79
Atrial Fibrillation Burden Signature and Near-Term Prediction of Stroke
Han, L., Askari, M., Altman, R. B., Schmitt, S. K., Fan, J., Bentley, J., Narayan, S. M., & Turakhia, M. P. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.005595 · Cited by 79
[Permanent atrial fibrillation in heart disease in Spain. The CARDIOTENS study 1999].
García‐Acuña, J. M., González‐Juanatey, J. R., Ezquerra, E. A., Maqueda, I. G., & Listerri, J. L. (2002) · PubMed · Cited by 78
Mechanism of mesenchymal stem cell–induced neuron recovery and anti-inflammation
Huang, P., Gebhart, N., Richelson, E., Brott, T. G., Meschia, J. F., & Zubair, A. C. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.05.007 · Cited by 79
Stroke Prevention in Nonvalvular Atrial Fibrillation
Albers, G. W., Atwood, J. E., Hirsh, J., Sherman, D. G., Hughes, R. A., & Connolly, S. J. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-727 · Cited by 78
Chagas Disease
Paixão, L. C., Ribeiro, A. L. P., Valácio, R. A., & Teixeira, A. L. (2009) · Stroke · doi:10.1161/strokeaha.109.560854 · Cited by 77
Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation
Salazar, C. A., del Aguila, D., & Cordova-Ramos, E. G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009893.pub2 · Cited by 76
Warfarin Prescribing in Atrial Fibrillation: The Impact of Physician, Patient, and Hospital Characteristics
Choudhry, N. K., Soumerai, S. B., Normand, S. T., Ross‐Degnan, D., Laupacis, A., & Anderson, G. M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.09.052 · Cited by 76
Observations on the transition from intermittent to permanent atrial fibrillation
Al‐Khatib, S. M., Wilkinson, W. E., Sanders, L. L., McCarthy, E. A., & Pritchett, E. L. C. (2000) · American Heart Journal · doi:10.1067/mhj.2000.107547 · Cited by 76
Potassium channel gene mutations rarely cause atrial fibrillation
Ellinor, P. T., Petrov-Kondratov, V. I., Zakharova, E., Nam, E. G., & MacRae, C. A. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-70 · Cited by 74
Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized thrombi
Wysokiński, W. E., Owen, W. G., Fass, D. N., Patrzałek, D., Murphy, L., & McBane, R. D. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00899.x · Cited by 72
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Etiology and Initial Investigations
Healey, J. S., Parkash, R., Pollak, T., Tsang, T. S. M., & Dorian, P. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.11.015 · Cited by 71

Authors: Wolf, P. A.
Corresponding author: Wolf, Philip A.
ORCID: Wolf, Philip A.
Venue: Archives of Internal Medicine
Publisher: American Medical Association (AMA)
Published: 1987-09-01
Volume: 147
Issue: 9
Pages: 1561
ISSN: 0003-9926 (ISSN-L)
DOI: 10.1001/archinte.1987.00370090041008
OpenAlex: W4292280632
Cited by: 1,108
References: 0
Citations by year: 2026: 5 · 2025: 16 · 2024: 25 · 2023: 22 · 2022: 19 · 2021: 27 · 2020: 34 · 2019: 36 · 2018: 47 · 2017: 38 · 2016: 63 · 2015: 62 · 2014: 47 · 2013: 57 · 2012: 45
FWCI: 4.73
Type: journal article
Language: en
Open access: closed
Locations: Archives of Internal Medicine (publishedVersion)
Funders: National Institute of Neurological Disorders and Stroke (1-RO1-NS-17950-01, N01 NS2 2398, IPO-INS-16367)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
Keywords: atrial fibrillation, stroke, older adults, stroke risk factors, Framingham Heart Study, cardiac arrhythmias, cardiovascular disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Atrial Fibrillation: A Major Contributor to Stroke in the Elderly: The Framingham Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks